Zanubrutinib in Relapsed/Refractory Mantle Cell Lymphoma

Zanubrutinib in Relapsed/Refractory Mantle Cell Lymphoma

obr

1 week
11 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
Report 0 0
Category:
Description:
Lori Leslie, MD Medical Oncologist, Regional Cancer Care Associates, considers the use of zanubrutinib in relapsed/refractory mantle cell lymphoma.
Up Next Autoplay